Rivian and Amazon are in talks to end the exclusivity part of the all-electric van deal the two companies signed in 2019. RIVN stock fell. Read More...
Investopedia
Pfizer Agrees to Buy Cancer Drug Maker Seagen for $43 Billion
Pfizer Inc. agreed to acquire cancer treatment company Seagen Inc. for $43 billion as it looks to incorporate cancer treatments into its products, creating a company with a combined market value of more than $260 billion. The biggest obstacle to completing the deal may be winning approval from U.S. antitrust regulators, according to the Wall Street Journal. If allowed to proceed, the deal would be among the largest in months, combining Seagen, with a market value of more than $30 billion, with Pfizer, worth $229 billion.
Add Comment